BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2017

Jun 21, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2017-06-16

Reporting Person: LAWLIS V BRYAN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-16	Common Stock	M	3750	$38.59	Acquired	19660	Direct
2017-06-16	Common Stock	S	3750	$90	Disposed	15910	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-16	Stock Option (right to buy) Common Stock	$38.59	M	3750	Disposed	2018-05-21	Common Stock (3750)	Direct

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017

F2: All shares sold at the same price.

F3: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.